Request Discount

Eczema Therapeutics Market (Drug Class - Calcineurin Inhibitors, PDE4 Inhibitors, Corticosteroids, and Others; Disease Indication - Atopic Dermatitis, and Contact Dermatitis; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : February, 2022

  • Rep Id : HC08739

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the eczema therapeutics market provides in-depth analysis of segments and sub-segments in the global as well as regional eczema therapeutics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional eczema therapeutics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global eczema therapeutics market. According to the report, the global eczema therapeutics market is projected to grow at a CAGR of 10% around the forecast period of 2021-2027, growing from over USD 18 billion in 2021 to over USD 32 billion in 2027.


Market Insight

Eczema is a childhood atopic disease associated with chronicity and impaired quality of life. Eczema is a chronically relapsing dermatosis that affects 9% to 20% of children in the US region and is more prevalent in children who belong to upper socioeconomic classes, smaller family sizes, and families with overzealous hygiene. The disease also affects 5.6% of young children and 3.8% of school children and adolescents in some parts of Hong Kong. Topical corticosteroids, macrolide immunosuppressants, and oral immunomodulating drugs for disease have been the therapy. The symptoms suffered by these children are lack of sleep, irritability, tiredness during the daytime, emotional stress, low self-esteem, psychological disturbance, skin dryness, erythema, oozing and crusting, and lichenification. Its treatment depends on the severity, distribution, and extent of the condition as well as patients' age. Therefore it is considered to be one of the challenging diseases for physicians and patients


The significant prevalence of atopic dermatitis and Business strategies are the key factors driving the eczema therapeutics market growth. The growing availability of sound reimbursement policies for eczema treatment coupled with highly developed medical infrastructure will considerably grow opportunities for the eczema therapeutics market in the upcoming future. Delays in product approvals from the regulatory authorities for the treatment of eczema, Termination of clinical trials directed at the development of the drug for eczema are a few of the factors that will restrain its market growth


Among the regions, North America accounted for the largest share in the global Eczema Therapeutics Market. Owing to the availability of medical reimbursement policies for the treatment of eczema in this region. Under the policies, doctor visits, appointments with specialists, and even other special treatments have been covered. However, the European region is anticipated to grow at the highest rate in the global Eczema Therapeutics Market over the forecast period. Owing to the increasing research and development activities and research institutes by the market players in this region is expected to grow its market. Moreover, increasing awareness of the availability of advanced treatment for the disease to fuel its growth in upcoming years


Eczema Therapeutics Market

Segment Covered

The report on global eczema therapeutics market covers segments such as drug class, disease indication, and distribution channel. On the basis of drug class, the sub-markets include calcineurin inhibitors, PDE4 inhibitors, corticosteroids, and others. On the basis of disease indication, the sub-markets include atopic dermatitis, and contact dermatitis. On the basis of distribution channel, the sub-markets include hospital pharmacy, retail pharmacy, and online pharmacy.


Companies Profiled:

The report provides profiles of the companies in the market such as Pfizer Inc, AstraZeneca plc, GlaxoSmithKline plc, Meda AB, Sanofi S.A., Encore Dermatology Inc, AbbieVie Inc, Hoffmann-La Roche AG, Novartis AG, and Regeneron Pharmaceuticals Inc..


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the eczema therapeutics market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount